Firms Say Randomized Controlled Trials For PFO Closure Devices Reasonable
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical and AGA Medical say they are ready to follow an FDA advisory panel's recommendations for premarket trials of PFO closure devices for the treatment of cryptogenic stroke